Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction
Completed · Phase 2 · Has a placebo group
Conditions studied: Pain
In brief
The purpose of this study was to evaluate analgesic efficacy and safety of hydrocodone/acetaminophen compared to placebo in moderate to severe pain following molar extraction.
Key facts
- Study ID
- NCT00935311
- Run by
- AbbVie (prior sponsor, Abbott)
- People needed
- 122
- Starts
- 2009-06-01
- Expected to finish
- 2009-08-01
- Last updated by the study team
- 2014-04-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who are in general good health, experiencing moderate to severe pain after surgical extraction of 2 or more third molars and who are willing to remain confined until the morning after surgery for study procedures
You may not qualify if…
- Allergies to study medications
- History of multiple drug allergies
- Unable to stop excluded medications
- Clinically significant laboratory abnormalities at Screening
- Significant medical condition at Screening
- Women who are pregnant or breast feeding
Where it is running
- Site Reference ID/Investigator# 20745 — Austin, Texas, United States
- Site Reference ID/Investigator# 20743 — San Marcos, Texas, United States
- Site Reference ID/Investigator# 20744 — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.